Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Nancy Davis

Associate Professor of Medicine & Urology

Vanderbilt University Medical Center

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

70%

Immunology

40%

Renal Cell Carcinoma

60%

Oncology

40%

Immunotherapy

40%

Cancer Therapy

30%

Targeted Therapy

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984

Article Link

Year:

2023

Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical Trial.

Article Link

Year:

2022

The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma

Article Link

Year:

2022

Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study

Article Link

Year:

2022

Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma

Article Link

Year:

2021

Assessment of gender representation in clinical trials leading to FDA approval for oncology therapeutics between 2014 and 2019: A systematic review-based cohort study.

Article Link

Year:

2021

Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma

Article Link

Year:

2021

Complete Pathologic Responses With Immunotherapy in Metastatic Renal Cell Carcinoma: Case Reports.

Article Link

Year:

2020

Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinoma.

Article Link

Year:

2020

Outcomes With Liver-Directed Therapy for Genitourinary Malignancies: Single-Institution Experience.

Article Link

Year:

2020

Collaborators10

Ulka Vaishampayan

Professor

University of Michigan

UNITED STATES

Joseph Kim

Yale University Yale Cancer Center

UNITED STATES

Tian Zhang

University of Texas Southwestern

UNITED STATES

Gregory Riedlinger

Rutgers Cancer Institute of New Jersey

UNITED STATES

xiande Liu

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

Leonard Appleman

Associate Professor

University of Pittsburgh

UNITED STATES

Yu Shyr

Professor and Chair

Vanderbilt University Medical Center

UNITED STATES

Yu-Wei Chen

Assistant Clinical Professor of Medicine

University of California, San Diego

UNITED STATES

Scott Haake

Assistant Professor

Vanderbilt University Medical Center

UNITED STATES

Ali Khaki

Clinical Assistant Professor

Stanford University

UNITED STATES

How do I reach out?

Meet Kite AI